Africa Western and Central vs Sweden: Access to anti-retroviral drugs, female
Africa Western and Central
83.1%
in 2024
Sweden
96.0%
in 2022
Africa Western and Central rank
14th
Sweden rank
14th
Access to anti-retroviral drugs, female over time
- Africa Western and Central
- Sweden
How they compare
Sweden currently reports 96.0% against 83.1% in Africa Western and Central, a difference of 12.9%.
That makes Sweden's figure about 1.2 times Africa Western and Central's.
Across all 23 years both countries report, Sweden has been ahead every year.
Africa Western and Central ranks 14th and Sweden ranks 14th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa Western and Central | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.6% | 41.9% | 37.3% | Sweden |
| 2010s | 40.2% | 89.5% | 49.3% | Sweden |
| 2020s | 70.2% | 95.7% | 25.5% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Africa Western and Central or Sweden?
- Sweden, at 96.0% against 83.1% in Africa Western and Central as of 2022.
- What is the difference in access to anti-retroviral drugs, female between Africa Western and Central and Sweden?
- 12.9%, with Sweden ahead.
- How many years of comparable data are there for Africa Western and Central and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Africa Western and Central and Sweden rank globally for access to anti-retroviral drugs, female?
- Africa Western and Central ranks 14th and Sweden ranks 14th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.